Protecting Advanced Therapies: The Role of Temperature-Controlled Packaging

According to industry forecasts, the number of approved biologics, vaccines, advanced cell and gene therapies, and other temperature-sensitive medical devices continue to grow each year. This growth is driven by increasing regulatory approvals, expanding clinical pipelines/markets, and investment in personalized medicine.

Cold Chain Transport

Unlike traditional medical devices and pharmaceuticals, temperature-sensitive products contain living cells or biological materials that cannot tolerate even brief temperature fluctuations. As a result, robust cold chain and cryogenic packaging has become a critical component of product quality, patient safety, and regulatory compliance.

Products commonly transported through the cold chain include vaccines, plasma-derived products, monoclonal antibodies, enzymes, diagnostic reagents, and certain biologics and pharmaceutical intermediates.

Cold chain transport provides controlled temperature environments typically ranging from 2°C to 8°C for refrigerated products, -20°C for frozen products, and as low as -80°C using dry ice. Refrigeration and insulated shipping systems make these temperature ranges achievable for storage, handling, and transportation.

Cold chain systems generally present less stringent storage requirements than cryogenic transport. Here, refrigeration can sustain product storage for extended periods when power is unavailable, and qualified passive shipping systems can maintain required temperatures for several days without external power.

Nevertheless, cold chain packaging remains susceptible to distribution hazards including vibration, shock, compression, altitude changes, and ambient temperature fluctuations. Consequently, shipping systems must be qualified to withstand both physical and thermal stresses encountered throughout the distribution cycle.

Cryogenic Transport

Cryogenic transport represents the most demanding application of temperature-controlled packaging systems. These systems preserve biological materials at ultra-low temperatures, typically between -150°C and -196°C, using liquid nitrogen instead of refrigerants. Products commonly transported under cryogenic conditions include cell and gene therapies, stem cells, CAR-T therapies, and cellular starting materials used in regenerative medicine.

Cryogenic shipments rely on specialized vacuum-insulated containers called dewars. These double-walled vessels minimize heat transfer through an evacuated insulation space, allowing liquid nitrogen vapor to maintain stable ultra-low temperatures for extended transit times.

Unlike cold chain packaging, cryogenic systems are designed not only to minimize heat gain but also to safely manage the physical behavior of liquid nitrogen throughout storage, handling, and transportation.

Joint Mission, High Stakes

Both cold chain and cryogenic transportation include advanced logistics systems designed to preserve highly sensitive biological materials throughout the storage and distribution system. Their shared mission is straightforward but demanding: maintain the required temperature range and product sterility throughout storage, handling, and transportation under defined conditions.

Although cryogenic transport is often discussed alongside cold chain logistics, it represents a specialized subset designed for the most temperature-sensitive products.

Regardless of temperature range, every cold chain shipping system consists of three primary components:

• An insulated shipping container that minimizes heat transfer from the external environment.

• A refrigerant system, such as gel packs, dry ice, or liquid nitrogen, that maintains the required internal temperature.

• Temperature monitoring devices that continuously record environmental conditions and provide documentation that storage requirements were maintained throughout distribution.

These specialized packaging systems operate within stringent FDA regulatory frameworks. Medical device and pharmaceutical companies must provide comprehensive documentation, environmental monitoring, and validated shipping processes are essential to demonstrate that products remain within their specified storage conditions throughout the supply chain.

Check back later this week to learn more about the challenges that temperature-sensitive packaging faces.